# PellePharm, Inc. — Form D

PellePharm, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-03. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-07-03
- Form: D
- Accession: 0001611568-18-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.5M
- Investors: 7
- Date of first sale: 2018-06-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315962

## Issuer

- Name: PellePharm, Inc.
- CIK: 0001611568
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 101 MISSION STREET, SUITE 2050, SAN FRANCISCO, CA, 94105
- Phone: (510) 502-6144

## Officers, directors & promoters (19)

| Name | Role | Location |
| --- | --- | --- |
| Ervin Epstein, M.D. | Director | San Francisco, CA |
| Neil Kumar, Ph.D. | Director | San Francisco, CA |
| Frank McCormick, Ph.D. | Director | San Francisco, CA |
| Sanuj Ravinddran, M.D. | Director | San Francisco, CA |
| Jean Y Tang, M.D., Ph.D. | Director | San Francisco, CA |
| Sanuj Ravinddran, M.D. | Executive Officer | San Francisco, CA |
| Sanuj Ravinddran, M.D. | Promoter | San Francisco, CA |
| Mark de Souza | Director | Hingham, MA |
| Mark de Souza | Executive Officer | Hingham, MA |
| Frank McCormick | Director | PALO ALTO, CA |
| Neil Kumar | Director | PALO ALTO, CA |
| Ervin Epstein, M.D. | Executive Officer | San Francisco, CA |
| Mark De Souza, Ph.D. | Director | Berkeley, CA |
| Mark De Souza, Ph.D. | Executive Officer | Berkeley, CA |
| Jean Tang, M.D., Ph.D. | Director | Stanford, CA |
| Ervin Epstein | Director | Orinda, CA |
| Ervin Epstein | Executive Officer | Orinda, CA |
| Jean Tang | Director | Stanford, CA |
| Katrin Andreasson | Director | Stanford, CA |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2016-08-17](https://search.stillhousedata.com/formd/0001611568-16-000001) | D | $7.5M | $3.2M |
| [2015-10-14](https://search.stillhousedata.com/formd/0000914760-15-000286) | D | $720K | $720K |
| [2015-07-24](https://search.stillhousedata.com/formd/0000914760-15-000236) | D | $4.5M | $4.5M |
| [2015-05-11](https://search.stillhousedata.com/formd/0000914760-15-000170) | D | $119K | $119K |
| [2015-04-21](https://search.stillhousedata.com/formd/0000914760-15-000145) | D | $1.8M | $1.8M |
| [2014-10-24](https://search.stillhousedata.com/formd/0001611568-14-000002) | D | $1.3M | $1.3M |
| [2014-07-21](https://search.stillhousedata.com/formd/0001611568-14-000001) | D | $476K | $476K |

## More

- [CIK 1611568 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1611568&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001611568-18-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.